UCB has unveiled data from a double-blind, placebo-controlled study, which found that Neupro (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure (NSBP) elevations associated with periodic limb movements during ...
Tags: RLS Patients, UCB
UCB has launched Neupro (Rotigotine Transdermal System) in US pharmacies for the treatment of Parkinson's disease (PD) and Restless Legs Syndrome (RLS). Neupro received the US Food and Drug Administration approval on 3 April 2012. UCB ...
Tags: Neupro, Rotigotine Transdermal System, PD, RLS